Tandem Diabetes (TNDM) Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes

Go back to Tandem Diabetes (TNDM) Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes
TANDEM DIABETES (NASDAQ: TNDM) Delayed: 16.87 -0.36 (2.09%)
Previous Close $17.23    52 Week High $12.48 
Open $17.13    52 Week Low $1.60 
Day High $17.15    P/E N/A 
Day Low $16.77    EPS $-6.33 
Volume 2,284,176